Activaero appoints chief business officer
Christian Pangratz takes the role
Pangratz joins Activaero from Nektar Therapeutics, in San Francisco, US, where he recently served as executive director of business development. He brings to Activaero 20 years of life science experience.
Pangratz will join the Activaero management team and lead all business development, marketing and alliance management activities. He replaces Henrik Luessen, who has decided to focus on his own consultancy firm, but will continue to support Activaero’s business development team on a part-time basis.
You may also like
Research & Development
Bayer expands global partnership with TetraScience to accelerate AI-driven scientific data management
Bayer is scaling TetraScience’s Scientific Data Foundry across its pharma and crop science R&D teams to unify and harmonise laboratory and CRO data. The expansion aims to streamline regulatory workflows and enable faster, AI-ready analysis across global programmes
Finance
HitGen secures Gates Foundation funding to advance drug discovery for tuberculosis, malaria and contraception
HitGen will use its DNA-encoded library platform to identify new drug leads for TB, malaria and non-hormonal contraception. The new Gates Foundation agreement expands on earlier collaboration to accelerate treatments for underserved diseases